XOMA Royalty (XOMA) Shares Outstanding (2010 - 2026)

XOMA Royalty (XOMA) reported Shares Outstanding (Entity) of $11.9 million for Q1 2026, little changed on a YoY basis from $12.0 million in Q1 2025, and little changed sequentially from $11.9 million in Q4 2025.

XOMA Royalty (XOMA) Shares Outstanding (2010 - 2026) Analysis & Trends

XOMA Royalty (XOMA) has 17 years of Shares Outstanding (Entity) data on file, last reported at $11.9 million in Q1 2026.

  • For the quarter ending Q1 2026, Shares Outstanding (Entity) changed 0.36% year-over-year to $11.9 million; the trailing twelve-month figure through Mar 2026 stood at $11.9 million (changed 0.36% YoY), and the FY2025 full-year result was $11.9 million, down 0.78% from the prior year.
  • Shares Outstanding (Entity) steadied at $11.9 million in Q1 2026, from $11.9 million in the prior quarter.
  • In the past five years, Shares Outstanding (Entity) ranged from a high of $12.1 million in Q2 2025 to a low of $11460.0 in Q1 2023.
  • A 5-year average of $8.5 million and a median of $11.5 million in 2022 frame the typical range for Shares Outstanding (Entity).
  • Across the five-year window, Shares Outstanding (Entity) slumped 99.9% in 2023 and soared 103120.11% in 2025, its largest moves.
  • Tracing XOMA's Shares Outstanding (Entity) over 5 years: stood at $11.5 million in 2022, then sank by 40.52% to $6.8 million in 2023, then jumped by 75.43% to $12.0 million in 2024, then decreased by 0.78% to $11.9 million in 2025, then climbed by 0.43% to $11.9 million in 2026.
  • Business Quant data shows XOMA's Shares Outstanding (Entity) at $11.9 million in Q1 2026, $11.9 million in Q4 2025, and $12.1 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 6,012.74 Bn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - 47.82 Bn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 118.76 Bn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 1.44 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 254.10 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 104.00 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - 400.00 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 62.06 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - 198.10 Mn
10 XOMA Royalty 478.42 Mn 412.34 Mn - 11.89 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 11.89 Mn
Dec 31, 2025 12.08 Mn
Sep 17, 2025 12.01 Mn
Jun 30, 2025 12.01 Mn
Mar 31, 2025 11.97 Mn
Dec 31, 2024 11.70 Mn
Sep 30, 2024 11.71 Mn
Jun 30, 2024 11.64 Mn
Mar 31, 2024 11,580.00
Dec 31, 2023 6.81 Mn
Sep 30, 2023 11,473.00
Jun 30, 2023 11,466.00
Mar 31, 2023 11,460.00
Dec 31, 2022 11.41 Mn
Sep 30, 2022 11.45 Mn
Jun 30, 2022 11.42 Mn
Mar 31, 2022 11.33 Mn
Dec 31, 2021 11.29 Mn
Sep 30, 2021 11.31 Mn
Jun 30, 2021 11.29 Mn